Chile

Chile

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
0.48 (0.40 - 0.57) 2019 Modelled IHME
0.48 (0.41 - 0.56) 2018 Modelled IHME
0.48 (0.41 - 0.56) 2017 Modelled IHME
0.48 (0.41 - 0.55) 2016 Modelled IHME
0.48 (0.41 - 0.55) 2015 Modelled IHME
0.48 (0.41 - 0.55) 2014 Modelled IHME
0.48 (0.41 - 0.56) 2013 Modelled IHME
0.49 (0.41 - 0.56) 2012 Modelled IHME
0.49 (0.42 - 0.57) 2011 Modelled IHME
0.5 (0.42 - 0.57) 2010 Modelled IHME
0.5 (0.43 - 0.58) 2009 Modelled IHME
0.51 (0.43 - 0.59) 2008 Modelled IHME
0.52 (0.43 - 0.60) 2007 Modelled IHME
0.52 (0.44 - 0.61) 2006 Modelled IHME
0.52 (0.44 - 0.62) 2005 Modelled IHME
0.52 (0.44 - 0.61) 2004 Modelled IHME
0.52 (0.44 - 0.61) 2003 Modelled IHME
0.52 (0.44 - 0.61) 2002 Modelled IHME
0.52 (0.44 - 0.61) 2001 Modelled IHME
0.52 (0.44 - 0.61) 2000 Modelled IHME
0.52 (0.44 - 0.60) 1999 Modelled IHME
0.52 (0.44 - 0.60) 1998 Modelled IHME
0.51 (0.44 - 0.60) 1997 Modelled IHME
0.51 (0.43 - 0.59) 1996 Modelled IHME
0.51 (0.43 - 0.59) 1995 Modelled IHME
0.51 (0.43 - 0.59) 1994 Modelled IHME
0.51 (0.43 - 0.59) 1993 Modelled IHME
0.52 (0.43 - 0.60) 1992 Modelled IHME
0.52 (0.43 - 0.61) 1991 Modelled IHME
0.52 (0.43 - 0.61) 1990 Modelled IHME
0.6 (0 - 1.30) 1999 Survey/reported Silveira TR et al, 1999
0.88 (0.37 - 1.71) 2015 Modelled WHO
0.1 (0 - 0.20) 2016 Modelled Razavi-Shearer et al, 2018
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.02 (0.01 - 0.03) 2019 Modelled IHME
0.02 (0.01 - 0.03) 2018 Modelled IHME
0.02 (0.01 - 0.03) 2017 Modelled IHME
0.02 (0.01 - 0.02) 2016 Modelled IHME
0.02 (0.01 - 0.02) 2015 Modelled IHME
0.02 (0.01 - 0.02) 2014 Modelled IHME
0.02 (0.01 - 0.02) 2013 Modelled IHME
0.02 (0.01 - 0.03) 2012 Modelled IHME
0.02 (0.01 - 0.03) 2011 Modelled IHME
0.02 (0.01 - 0.03) 2010 Modelled IHME
0.02 (0.01 - 0.03) 2009 Modelled IHME
0.02 (0.01 - 0.03) 2008 Modelled IHME
0.02 (0.01 - 0.03) 2007 Modelled IHME
0.02 (0.01 - 0.03) 2006 Modelled IHME
0.02 (0.01 - 0.03) 2005 Modelled IHME
0.04 (0.02 - 0.05) 2004 Modelled IHME
0.07 (0.05 - 0.10) 2003 Modelled IHME
0.11 (0.08 - 0.15) 2002 Modelled IHME
0.14 (0.10 - 0.19) 2001 Modelled IHME
0.16 (0.11 - 0.21) 2000 Modelled IHME
0.16 (0.11 - 0.21) 1999 Modelled IHME
0.16 (0.11 - 0.21) 1998 Modelled IHME
0.16 (0.11 - 0.22) 1997 Modelled IHME
0.16 (0.11 - 0.21) 1996 Modelled IHME
0.16 (0.11 - 0.22) 1995 Modelled IHME
0.16 (0.11 - 0.22) 1994 Modelled IHME
0.16 (0.11 - 0.22) 1993 Modelled IHME
0.17 (0.11 - 0.22) 1992 Modelled IHME
0.17 (0.11 - 0.22) 1991 Modelled IHME
0.17 (0.11 - 0.23) 1990 Modelled IHME
0.28 (0.11 - 0.57) 2015 Modelled WHO
Showing out of
Show more
Technical notes

Number of people living with chronic HBV

National
Download
Value Year Type Source
69,135 (57,380 - 81,397) 1990 Modelled IHME
69,906 (58,559 - 81,667) 1991 Modelled IHME
70,688 (59,511 - 81,988) 1992 Modelled IHME
71,504 (59,890 - 82,614) 1993 Modelled IHME
72,365 (60,873 - 83,250) 1994 Modelled IHME
73,279 (61,501 - 84,503) 1995 Modelled IHME
74,252 (62,663 - 85,713) 1996 Modelled IHME
75,267 (63,913 - 87,200) 1997 Modelled IHME
76,297 (65,246 - 88,409) 1998 Modelled IHME
77,312 (66,275 - 90,416) 1999 Modelled IHME
78,296 (66,800 - 92,086) 2000 Modelled IHME
79,314 (67,572 - 92,895) 2001 Modelled IHME
80,394 (68,087 - 94,166) 2002 Modelled IHME
81,462 (68,747 - 95,636) 2003 Modelled IHME
82,447 (69,358 - 96,807) 2004 Modelled IHME
83,286 (69,868 - 97,983) 2005 Modelled IHME
83,690 (70,226 - 97,958) 2006 Modelled IHME
83,587 (70,285 - 97,425) 2007 Modelled IHME
83,234 (70,450 - 96,073) 2008 Modelled IHME
82,877 (70,431 - 95,569) 2009 Modelled IHME
82,762 (70,258 - 95,612) 2010 Modelled IHME
82,822 (70,278 - 95,374) 2011 Modelled IHME
82,853 (70,197 - 95,141) 2012 Modelled IHME
82,940 (70,128 - 95,012) 2013 Modelled IHME
83,174 (70,264 - 95,774) 2014 Modelled IHME
83,701 (70,666 - 96,500) 2015 Modelled IHME
84,851 (72,355 - 97,973) 2016 Modelled IHME
86,243 (72,916 - 101,081) 2017 Modelled IHME
87,231 (74,022 - 101,906) 2018 Modelled IHME
88,028 (73,624 - 103,336) 2019 Modelled IHME
26,000 (9,000 - 43,000) 2016 Modelled Razavi-Shearer et al, 2018
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
3.29 (2.44 - 4.38) 2019 Modelled IHME
3.26 (2.40 - 4.33) 2018 Modelled IHME
3.24 (2.39 - 4.33) 2017 Modelled IHME
3.21 (2.37 - 4.27) 2016 Modelled IHME
3.26 (2.41 - 4.31) 2015 Modelled IHME
3.45 (2.55 - 4.53) 2014 Modelled IHME
3.94 (2.90 - 5.15) 2013 Modelled IHME
4.44 (3.28 - 5.80) 2012 Modelled IHME
4.84 (3.59 - 6.34) 2011 Modelled IHME
5.07 (3.75 - 6.66) 2010 Modelled IHME
4.99 (3.68 - 6.56) 2009 Modelled IHME
4.81 (3.54 - 6.29) 2008 Modelled IHME
4.77 (3.52 - 6.25) 2007 Modelled IHME
4.7 (3.48 - 6.15) 2006 Modelled IHME
4.72 (3.49 - 6.16) 2005 Modelled IHME
4.83 (3.56 - 6.30) 2004 Modelled IHME
4.83 (3.55 - 6.29) 2003 Modelled IHME
4.74 (3.48 - 6.20) 2002 Modelled IHME
4.7 (3.44 - 6.16) 2001 Modelled IHME
4.54 (3.30 - 5.96) 2000 Modelled IHME
4.56 (3.33 - 5.99) 1999 Modelled IHME
4.65 (3.39 - 6.10) 1998 Modelled IHME
4.74 (3.46 - 6.27) 1997 Modelled IHME
4.88 (3.55 - 6.49) 1996 Modelled IHME
4.83 (3.49 - 6.47) 1995 Modelled IHME
4.62 (3.36 - 6.19) 1994 Modelled IHME
4.45 (3.25 - 5.97) 1993 Modelled IHME
4.43 (3.26 - 5.89) 1992 Modelled IHME
4.73 (3.49 - 6.28) 1991 Modelled IHME
5.14 (3.75 - 6.81) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
598 (444 - 797) 2019 Modelled IHME
589 (433 - 783) 2018 Modelled IHME
580 (429 - 776) 2017 Modelled IHME
566 (419 - 753) 2016 Modelled IHME
569 (420 - 751) 2015 Modelled IHME
595 (440 - 782) 2014 Modelled IHME
673 (496 - 881) 2013 Modelled IHME
753 (557 - 984) 2012 Modelled IHME
814 (603 - 1,066) 2011 Modelled IHME
844 (625 - 1,110) 2010 Modelled IHME
824 (607 - 1,083) 2009 Modelled IHME
786 (578 - 1,029) 2008 Modelled IHME
772 (570 - 1,011) 2007 Modelled IHME
754 (558 - 986) 2006 Modelled IHME
749 (555 - 979) 2005 Modelled IHME
760 (560 - 993) 2004 Modelled IHME
753 (554 - 982) 2003 Modelled IHME
732 (538 - 959) 2002 Modelled IHME
719 (526 - 942) 2001 Modelled IHME
687 (500 - 902) 2000 Modelled IHME
683 (499 - 896) 1999 Modelled IHME
688 (502 - 902) 1998 Modelled IHME
693 (506 - 917) 1997 Modelled IHME
706 (514 - 937) 1996 Modelled IHME
689 (498 - 923) 1995 Modelled IHME
650 (473 - 871) 1994 Modelled IHME
618 (451 - 829) 1993 Modelled IHME
606 (446 - 807) 1992 Modelled IHME
637 (471 - 846) 1991 Modelled IHME
682 (498 - 904) 1990 Modelled IHME
1,107 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
16 (11 - 23) 2019 Modelled IHME
16 (11 - 23) 2018 Modelled IHME
16 (11 - 23) 2017 Modelled IHME
16 (11 - 23) 2016 Modelled IHME
16 (11 - 23) 2015 Modelled IHME
16 (11 - 23) 2014 Modelled IHME
17 (12 - 24) 2013 Modelled IHME
18 (12 - 25) 2012 Modelled IHME
18 (13 - 25) 2011 Modelled IHME
18 (13 - 26) 2010 Modelled IHME
19 (13 - 26) 2009 Modelled IHME
19 (13 - 26) 2008 Modelled IHME
19 (13 - 26) 2007 Modelled IHME
19 (13 - 26) 2006 Modelled IHME
19 (13 - 26) 2005 Modelled IHME
19 (13 - 26) 2004 Modelled IHME
19 (13 - 26) 2003 Modelled IHME
19 (13 - 26) 2002 Modelled IHME
19 (14 - 27) 2001 Modelled IHME
19 (14 - 27) 2000 Modelled IHME
19 (14 - 27) 1999 Modelled IHME
19 (14 - 27) 1998 Modelled IHME
19 (14 - 27) 1997 Modelled IHME
20 (14 - 27) 1996 Modelled IHME
20 (14 - 27) 1995 Modelled IHME
20 (14 - 27) 1994 Modelled IHME
19 (14 - 27) 1993 Modelled IHME
20 (14 - 27) 1992 Modelled IHME
20 (14 - 27) 1991 Modelled IHME
20 (14 - 28) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Coverage of HepB birth dose

Newborns
Download
Value (%) Year Type Source
65 2019 Survey/reported WHO/UNICEF
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
95 2018 Survey/reported WHO/UNICEF
93 2017 Survey/reported WHO/UNICEF
95 2016 Survey/reported WHO/UNICEF
97 2015 Survey/reported WHO/UNICEF
95 2014 Survey/reported WHO/UNICEF
90 2013 Survey/reported WHO/UNICEF
90 2012 Survey/reported WHO/UNICEF
94 2011 Survey/reported WHO/UNICEF
92 2010 Survey/reported WHO/UNICEF
94 2009 Survey/reported WHO/UNICEF
95 2008 Survey/reported WHO/UNICEF
92 2007 Survey/reported WHO/UNICEF
95 2006 Survey/reported WHO/UNICEF
96 2019 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
0 (0 - 0) 2016 Survey/reported Harm Reduction International, 2016
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Yes (for risk groups)
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
No
At least one opioid substitution therapy (OST) program operational
No
NSP in at least one prison
No
OST in at least one prison
No
% of substance use disorder facilities offering hepatitis testing
Many (31-60%)

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
0.61 (0.50 - 0.74) 2019 Modelled IHME
0.6 (0.49 - 0.73) 2018 Modelled IHME
0.59 (0.49 - 0.72) 2017 Modelled IHME
0.59 (0.48 - 0.71) 2016 Modelled IHME
0.58 (0.48 - 0.70) 2015 Modelled IHME
0.57 (0.47 - 0.70) 2014 Modelled IHME
0.57 (0.47 - 0.69) 2013 Modelled IHME
0.57 (0.47 - 0.69) 2012 Modelled IHME
0.57 (0.46 - 0.68) 2011 Modelled IHME
0.56 (0.46 - 0.68) 2010 Modelled IHME
0.56 (0.46 - 0.68) 2009 Modelled IHME
0.55 (0.45 - 0.67) 2008 Modelled IHME
0.55 (0.45 - 0.66) 2007 Modelled IHME
0.54 (0.44 - 0.66) 2006 Modelled IHME
0.54 (0.44 - 0.65) 2005 Modelled IHME
0.53 (0.44 - 0.64) 2004 Modelled IHME
0.53 (0.44 - 0.64) 2003 Modelled IHME
0.53 (0.43 - 0.63) 2002 Modelled IHME
0.52 (0.43 - 0.63) 2001 Modelled IHME
0.52 (0.43 - 0.63) 2000 Modelled IHME
0.53 (0.43 - 0.63) 1999 Modelled IHME
0.53 (0.44 - 0.64) 1998 Modelled IHME
0.54 (0.44 - 0.65) 1997 Modelled IHME
0.55 (0.45 - 0.66) 1996 Modelled IHME
0.55 (0.45 - 0.67) 1995 Modelled IHME
0.55 (0.45 - 0.66) 1994 Modelled IHME
0.55 (0.45 - 0.66) 1993 Modelled IHME
0.55 (0.45 - 0.66) 1992 Modelled IHME
0.55 (0.45 - 0.67) 1991 Modelled IHME
0.55 (0.45 - 0.67) 1990 Modelled IHME
0.3 (0.20 - 0.50) 2015 Modelled Blach et al, 2017
Showing out of
Show more
Technical notes

Number of people living with chronic HCV (RNA+/cAg)

National
Download
Value Year Type Source
72,792 (59,785 - 88,507) 1990 Modelled IHME
74,071 (61,004 - 89,923) 1991 Modelled IHME
75,266 (62,075 - 91,021) 1992 Modelled IHME
76,395 (62,723 - 92,252) 1993 Modelled IHME
77,464 (63,557 - 93,412) 1994 Modelled IHME
78,479 (64,488 - 95,249) 1995 Modelled IHME
79,061 (65,092 - 95,477) 1996 Modelled IHME
79,057 (65,080 - 95,086) 1997 Modelled IHME
78,823 (64,898 - 94,576) 1998 Modelled IHME
78,729 (64,712 - 94,481) 1999 Modelled IHME
79,181 (64,894 - 95,440) 2000 Modelled IHME
80,169 (65,790 - 96,227) 2001 Modelled IHME
81,359 (66,988 - 97,416) 2002 Modelled IHME
82,678 (68,116 - 99,268) 2003 Modelled IHME
84,057 (68,986 - 101,547) 2004 Modelled IHME
85,434 (69,986 - 103,472) 2005 Modelled IHME
86,929 (70,877 - 105,249) 2006 Modelled IHME
88,637 (72,549 - 107,195) 2007 Modelled IHME
90,452 (74,187 - 108,997) 2008 Modelled IHME
92,236 (75,461 - 111,547) 2009 Modelled IHME
93,834 (76,528 - 113,810) 2010 Modelled IHME
95,195 (78,012 - 115,057) 2011 Modelled IHME
96,425 (79,057 - 117,231) 2012 Modelled IHME
97,637 (80,153 - 118,722) 2013 Modelled IHME
98,954 (81,270 - 120,329) 2014 Modelled IHME
100,564 (83,203 - 122,661) 2015 Modelled IHME
103,318 (85,057 - 125,632) 2016 Modelled IHME
106,420 (87,114 - 128,674) 2017 Modelled IHME
108,573 (89,057 - 131,327) 2018 Modelled IHME
110,231 (90,503 - 133,795) 2019 Modelled IHME
57,000 (31,000 - 94,000) 2015 Modelled Blach et al, 2017
Showing out of
Show more

HCV-related death rate

National
Download
Value (per 100,000) Year Type Source
11.7 (9.26 - 14.50) 2019 Modelled IHME
11.5 (9.09 - 14.30) 2018 Modelled IHME
11.4 (8.94 - 14.10) 2017 Modelled IHME
11.3 (8.84 - 13.90) 2016 Modelled IHME
11.4 (9.03 - 14) 2015 Modelled IHME
11.2 (8.83 - 13.80) 2014 Modelled IHME
10.9 (8.64 - 13.50) 2013 Modelled IHME
10.5 (8.32 - 13.10) 2012 Modelled IHME
10.2 (8.11 - 12.70) 2011 Modelled IHME
10.1 (8.08 - 12.60) 2010 Modelled IHME
9.97 (7.90 - 12.40) 2009 Modelled IHME
9.63 (7.59 - 12) 2008 Modelled IHME
9.6 (7.52 - 12) 2007 Modelled IHME
9.51 (7.50 - 11.80) 2006 Modelled IHME
9.55 (7.57 - 11.90) 2005 Modelled IHME
9.8 (7.79 - 12.20) 2004 Modelled IHME
9.83 (7.79 - 12.20) 2003 Modelled IHME
9.69 (7.66 - 12.10) 2002 Modelled IHME
9.66 (7.61 - 12.10) 2001 Modelled IHME
9.36 (7.32 - 11.80) 2000 Modelled IHME
9.41 (7.36 - 11.90) 1999 Modelled IHME
9.56 (7.46 - 12) 1998 Modelled IHME
9.72 (7.54 - 12.20) 1997 Modelled IHME
10 (7.69 - 12.60) 1996 Modelled IHME
9.88 (7.64 - 12.40) 1995 Modelled IHME
9.47 (7.33 - 11.90) 1994 Modelled IHME
9.19 (7.15 - 11.50) 1993 Modelled IHME
9.18 (7.14 - 11.50) 1992 Modelled IHME
9.84 (7.62 - 12.30) 1991 Modelled IHME
10.7 (8.30 - 13.50) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
2,128 (1,685 - 2,647) 2019 Modelled IHME
2,087 (1,644 - 2,577) 2018 Modelled IHME
2,044 (1,601 - 2,533) 2017 Modelled IHME
1,989 (1,562 - 2,457) 2016 Modelled IHME
1,988 (1,575 - 2,443) 2015 Modelled IHME
1,927 (1,524 - 2,378) 2014 Modelled IHME
1,863 (1,478 - 2,313) 2013 Modelled IHME
1,778 (1,411 - 2,218) 2012 Modelled IHME
1,711 (1,364 - 2,130) 2011 Modelled IHME
1,691 (1,346 - 2,105) 2010 Modelled IHME
1,646 (1,304 - 2,049) 2009 Modelled IHME
1,574 (1,240 - 1,957) 2008 Modelled IHME
1,555 (1,217 - 1,937) 2007 Modelled IHME
1,524 (1,203 - 1,896) 2006 Modelled IHME
1,518 (1,203 - 1,889) 2005 Modelled IHME
1,542 (1,226 - 1,926) 2004 Modelled IHME
1,534 (1,216 - 1,904) 2003 Modelled IHME
1,497 (1,183 - 1,870) 2002 Modelled IHME
1,477 (1,164 - 1,854) 2001 Modelled IHME
1,416 (1,107 - 1,781) 2000 Modelled IHME
1,409 (1,101 - 1,774) 1999 Modelled IHME
1,415 (1,104 - 1,773) 1998 Modelled IHME
1,422 (1,103 - 1,790) 1997 Modelled IHME
1,445 (1,111 - 1,817) 1996 Modelled IHME
1,409 (1,090 - 1,772) 1995 Modelled IHME
1,334 (1,033 - 1,670) 1994 Modelled IHME
1,276 (993 - 1,596) 1993 Modelled IHME
1,258 (977 - 1,568) 1992 Modelled IHME
1,327 (1,028 - 1,662) 1991 Modelled IHME
1,426 (1,102 - 1,799) 1990 Modelled IHME
1,118 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
37 (27 - 46) 2019 Modelled IHME
37 (27 - 46) 2018 Modelled IHME
37 (28 - 46) 2017 Modelled IHME
37 (27 - 46) 2016 Modelled IHME
36 (27 - 46) 2015 Modelled IHME
36 (27 - 46) 2014 Modelled IHME
36 (27 - 46) 2013 Modelled IHME
36 (26 - 45) 2012 Modelled IHME
36 (26 - 45) 2011 Modelled IHME
36 (26 - 45) 2010 Modelled IHME
35 (26 - 45) 2009 Modelled IHME
35 (26 - 45) 2008 Modelled IHME
35 (26 - 45) 2007 Modelled IHME
35 (26 - 45) 2006 Modelled IHME
35 (26 - 45) 2005 Modelled IHME
35 (26 - 45) 2004 Modelled IHME
35 (26 - 45) 2003 Modelled IHME
35 (26 - 45) 2002 Modelled IHME
35 (26 - 44) 2001 Modelled IHME
35 (26 - 44) 2000 Modelled IHME
35 (26 - 44) 1999 Modelled IHME
35 (25 - 44) 1998 Modelled IHME
35 (25 - 44) 1997 Modelled IHME
34 (25 - 44) 1996 Modelled IHME
34 (25 - 44) 1995 Modelled IHME
34 (25 - 44) 1994 Modelled IHME
34 (25 - 44) 1993 Modelled IHME
34 (25 - 44) 1992 Modelled IHME
34 (25 - 43) 1991 Modelled IHME
34 (25 - 43) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
0 (0 - 0) 2016 Survey/reported Harm Reduction International, 2016
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Yes (for risk groups)
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
No
At least one opioid substitution therapy (OST) program operational
No
NSP in at least one prison
No
OST in at least one prison
No
% of substance use disorder facilities offering hepatitis testing
Many (31-60%)

Overview

HBV elimination goal
HCV elimination goal

Hepatitis related deaths (national)

Modelled

HBV
598
2019
(444 - 797)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
2,128
2019
(1,685 - 2,647)
IHME

Survey/surveillance

No data available
HCV chart

Prevalence PWID

No data available

Birth dose vaccination coverage (national)

Survey/surveillance

HBV
65 (%)
2019
WHO/UNICEF

No. of syringes/PWID/year

Survey/surveillance

HCV
0
2016
(0 - 0)
Harm Reduction International, 2016
Eligible for HBV generic medicines
Eligible for HCV generic medicines